Abstracts

CRITICAL CARE OF COVID-19

The novel coronavirus of 2019 (SARS-CoV-2) has resulted in an increased incidence of patients admitted to intensive care units (ICUs). On average 5 percent (ranges of 3-80% have been reported) of patients with COVID-19 require ICU admission. Unfortunately, a vast majority of these ICU patients contribute to the mortality seen with this disease. The chief…

IMAGING VIRAL LIFE CYCLES

Understanding viral replication and spread for a longest time depended on bulk analysis of infected cells and mostly used transformed cell lines in tissue culture. Advances in imaging methods and labeling tools more recently allowed studying individual infection events and specific stages of the infection cycle. This includes analysis of trafficking and morphological changes of…

LIVE-CELL IMAGING: CAPSID TRAFFICKING TO THE NUCLEUS

Over the past decade, the role of the mature HIV-1 capsid in viral replication has undergone a major paradigm shift. It became increasingly clear that the simple view of the capsid as a mere proteinaceous wrapper encasing the viral genome, which becomes obsolete soon after cytosolic entry, is incorrect. Today it is no longer debated…

HIV CASCADE OF CARE AMONG MEN WHO HAVE SEX WITH MEN IN CANADA’S 3 LARGEST CITIES

Treatment as prevention strategies have been variously applied across provinces in Canada. We estimated HIV care cascade indicators and correlates of unsuppressed viral load(VL) among gay, bisexual and other men who have sex with men(GBM) recruited in Montreal, Toronto and Vancouver. Sexually active GBM, aged ?16 years, were recruited through respondent-driven sampling(RDS) from February 2017…

REDUCTION IN INFECTIOUS SARS-CoV-2 IN TREATMENT STUDY OF COVID-19 WITH MOLNUPIRAVIR

The emergence of SARS-CoV-2 viral variants threatens current anti-viral and preventative strategies, including monoclonal antibodies and vaccines. Critically, the limited supply of vaccines and the complex logistics surrounding the delivery of infusion-based therapies herald the need for an easily produced, distributed, and specific direct-acting antiviral for COVID-19 that limits progression of illness and ideally prevents…

MARTIN DELANEY PRESENTATION

Vaccine Nationalism is Killing Us: How Inequities in Research and Access to SARS-CoV-2 Vaccines Will Perpetuate the Pandemic This presentation will include a conversation among the panelists as they discuss the worldwide struggle for access to antiretroviral therapy and the current battle to ensure everyone is vaccinated against SARS-CoV-2 across the planet. Panelists will describe…

NEUTRALIZING ANTIBODIES AGAINST CORONAVIRUSES

Neutralizing monoclonal antibodies against SARS-CoV-2 are being used as therapeutics against COVID-19. The Bjorkman laboratory is investigating the mechanisms of virus neutralization by human antibodies that bind the SARS-CoV-2 spike protein. Using structural techniques, including single-particle cryo-electron microscopy and X-ray crystallography, the laboratory has solved spike trimer-antibody structures that allow classifying antibodies with respect to…